insights_auto
为什么 ALMKT 下跌了 11.29%?
深入探索chevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€0.12
arrow_downward
-11.29%(-0.016) 1 天
10月2日, GMT+2 17:35:22 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 ALMKT 生成关键数据洞见…
开盘价
€0.13
最高价
€0.14
最低价
€0.11
市值
2491.52万
平均成交量
43.35万
成交量
177.59万
市盈率
1.02
52 周最高价
€0.23
52 周最低价
€0.07
每股收益
€0.12
流通股数
1.95亿
员工人数
59
开盘价
€0.13
最高价
€0.14
最低价
€0.11
市值
2491.52万
平均成交量
43.35万
成交量
177.59万
市盈率
1.02
52 周最高价
€0.23
52 周最低价
€0.07
每股收益
€0.12
流通股数
1.95亿
员工人数
59
新闻报道
来自网络来源和新闻合作伙伴
TradingKey
·
10小时前
标普500 vs 纳斯达克100：长期投资哪个更好？
Межа. Новини України.
·
1天前
就业数据弱于预期提振美股纳斯达克指数盘中刷新纪录| 乌克兰新闻
资料
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA简介